Styryl acrylonitrile compounds and their use to promote myelopoiesis
CA 2463133 A1 · Owner: The Hospital For Sick Children · Inventors: Rounova, Olga B.; Grunberger, Thomas; Sharfe, Nigel
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention relates to the use of organic compounds styryl acrylonitrile , compounds to promote myelopoiesis. These compounds thefore may be used to treat a subject suffering from neutropenia and other conditions which would benefit from increased myelopoieses. Moreover the compounds may be used to , treat hematopoietic cells ex-vivo to promote myelopoiesis and therefore may be used advantageously in bone marrow or peripheral blood stem cell transplant.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed October 11, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended October 11, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by October 11, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.